Tissue Chips in Space

The International Space Station (ISSInternational Space Station) U.S. National Laboratory held an Additive Manufacturing in Space Workshop virtual event on July 28, 2020, organized and sponsored by the Center for the Advancement of Science in Space (CASIS(Abbreviation: CASIS™) The nonprofit organization that manages the ISS National Lab, which receives at least 50 percent of the U.S. research allocation on the International Space Station to facilitate research that benefits humanity (NASA manages the other 50% and focuses on research for space exploration purposes).), manager of the ISS National Lab.

Paper presented at the 70th International Astronautical Congress, 21-25 October 2019, Washington, D.C., United States

The ISS National Lab in collaboration with the National Institutes of Health’s National Center for Advancing Translational Sciences and the National Institute of Biomedical Imaging and Bioengineering at the NIH developed the “Tissue Chips in Space” initiative to promote and fund research into human physiology and disease in low Earth orbit(Abbreviation: LEO) The orbit around the Earth that extends up to an altitude of 2,000 km (1,200 miles) from Earth’s surface. The International Space Station’s orbit is in LEO, at an altitude of approximately 250 miles. that will translate into advancements in Earth-based medicine. This report provides an overview of the Tissue Chips in Space initiative, an update on the its current status, and a discussion of its potential long-term benefits.

Download this Report.